Aqua Bio Technology ASA: Terms of the Subsequent Offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN Reference is made to the stock exchange announcements by Aqua Bio Technology ASA ("ABTEC" or the "Company") on 12 February 2026 regarding the completion of a private placement that raised NOK 10 million in gross proceeds, to be settled through both conversion of previously incurred debt and through cash payments (the "Private Placement") and a subsequent offering of new shares in the Company (the "Subsequent Offering"). The Subsequent Offering consists of an offering of up to 800,000 new shares in the Company (the "Offer Shares") directed towards the shareholders of the Company as of 12 February 2026 (as registered in the VPS on 16 February 2026) (the "Record Date"), except: (i) shareholders who were allocated shares in the Private Placement, and (ii) shareholders who are resident in a jurisdiction where such offering would be unlawful, or would require any prospectus filing, registration or similar action (the "Eligible Shareholders"). The subscription period in the Subsequent Offering commences on 12 March 2026 at 09:00 hours (CET) and will end on 19 March 2026 at 16:30 hours (CET) (the "Subscription Period"). The subscription price per Offer Share is NOK 5.00 (the "Subscription Price"), which is equal to the subscription price in the Private Placement. If fully subscribed, the Subsequent Offering will raise gross proceeds of NOK 4,000,000. In the Subsequent Offering, Eligible Shareholders will be granted non-tradable subscription rights (the "Subscription Rights") that, subject to applicable law, provide preferential rights to subscribe for and be allocated Offer Shares at the Subscription Price. In addition, the following types of investors shall have a secondary right to subscribe for the Offer Shares: (i) ABTEC shareholders and other investors who participated in the Private Placement, and (ii) other subscribers without Subscription Rights (jointly, the "Secondary Subscribers") subject to a minimum allocation of NOK 50,000. The Secondary Subscribers may subscribe for Offer Shares that have not been subscribed and allocated to Eligible Shareholders. The Eligible Shareholders will be granted 0.0103 Subscription Rights for each existing share registered as held by such Eligible Shareholder as of the Record Date, rounded down to the nearest whole number of Subscription Rights. The number of Subscription Rights granted has been calculated based on the number of shares outstanding in the Company prior to completion of the reverse share split completed in February 2026. Each whole Subscription Right provides a preferential right to subscribe for, and be allocated, one Offer Share at the Subscription Price. Over-subscription will be permitted. Subscription without Subscription Rights will not be permitted, other than by Secondary Subscribers. The Subscription Rights must be used to subscribe for Offer Shares before the expiry of the Subscription Period on 19 March 2026 at 16:30 hours (CET). Subscription Rights that are not used to subscribe for Offer Shares before 16:30 hours (CET) on 19 March 2026 will have no value and will lapse without compensation to the holder. The Subscription Rights will not be listed on Euronext Expand or any other regulated market or trading venue. Completion of the Subsequent Offering is subject to: (i) all necessary corporate resolutions for consummating the Subsequent Offering, including the share capital increase pertaining to the Subsequent Offering having been validly passed, (ii) valid subscription of the Offer Shares and the allocated Offer Shares having been fully paid, and (iii) registration of the share capital increase in the Norwegian Register of Business Enterprises (jointly, the "Subsequent Offering Conditions"). The Subsequent Offering will be cancelled if the Subsequent Offering Conditions are not fulfilled and may be cancelled by the Company at its sole discretion for any other reason whatsoever prior to such time when the share capital increase relating to the Subsequent Offering has been registered with the Norwegian Register of Business Enterprises. Listing of the Offer Shares may require that the Company prepares and publishes a prospectus to be approved by the Norwegian Financial Supervisory Authority (the "Prospectus"), which is currently expected to be published at the end of April 2026. The Offer Shares will be delivered as listed shares of the Company (i.e. with ISIN NO 0013735894) to the extent exemptions from the requirement to publish a prospectus in connection with listing of shares is available. If all of the Offer Shares are subscribed for, the Offer Shares will initially be delivered on a separate non-tradable ISIN awaiting publication of the Prospectus. An invitation letter (the "Invitation Letter") will be prepared in connection with the Subsequent Offering, which sets out the terms and conditions for the Subsequent Offering and includes a description of certain risk factors pertaining to the Company, its shares and the Subsequent Offering. The Invitation Letter will be made available prior to the start of the Subscription Period.

IMPORTANT INFORMATION This announcement is not an offer to sell or a solicitation of offers to purchase or subscribe for shares. Copies of this announcement may not be sent to jurisdictions, or distributed in or sent from jurisdictions, in which this is barred or prohibited by law. The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, in any jurisdiction in which such offer or solicitation would be unlawful absent registration, or an exemption from registration or qualification under the securities laws of any jurisdiction. This document is not for publication or distribution in, directly or indirectly, Australia, Canada, Japan, Hong Kong or the United States or any other jurisdiction in which such release, publication or distribution would be unlawful, and it does not constitute an offer or invitation to subscribe for or purchase any securities in such countries or in any other jurisdiction. In particular, the document and the information contained herein should not be distributed or otherwise transmitted into the United States or to publications with a general circulation in the United States of America. This announcement is not an offer for sale of securities in the United States. Securities may not be offered or sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration under the U.S. Securities Act of 1933, as amended (the "Securities Act"). The Company does not intend to register any part of the offering in the United States or to conduct a public offering in the United States of the shares to which this document relates. This announcement is for information purposes only and is not to be relied upon in substitution for the exercise of independent judgment. It is not intended as investment advice and under no circumstances is it to be used or considered as an offer to sell, or a solicitation of an offer to buy any securities or a recommendation to buy or sell any securities of the Company. This announcement and any materials distributed in connection with this announcement may contain certain forward-looking statements. By their nature, forward-looking statements involve risk and uncertainty because they reflect current expectations and assumptions as to future events and circumstances that may not prove accurate. A number of material factors could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. The Company expressly disclaims any obligation or undertaking to update, review or revise any statement contained in this announcement whether as a result of new information, future developments or otherwise.

Contacts Kristian Flaten CEO & CFO Aqua Bio Technology ASA

Phone: +47 9509 2322 Email: kf@aquabiotech.no

About Us Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in skincare and nonfood. The group has distribution towards B2C and B2B, and offers freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-03-11 07:30 CET.